Bristol-Myers Squibb has discontinued the manufacturing of Teslac (testolactone) 50mg tablets. Once current inventories are depleted, Teslac will no longer be available in the United States. Healthcare providers should begin to convert Teslac-treated patients to alternative therapies.

For more information call (800) 631-5244 or visit www.fda.gov/cder/drug/shortages/teslac.pdf.